592 related articles for article (PubMed ID: 26514656)
1. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM
Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656
[TBL] [Abstract][Full Text] [Related]
2. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.
Oberlander TF; Grunau RE; Fitzgerald C; Papsdorf M; Rurak D; Riggs W
Pediatrics; 2005 Feb; 115(2):411-25. PubMed ID: 15687451
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
[TBL] [Abstract][Full Text] [Related]
4. Hub distribution of the brain functional networks of newborns prenatally exposed to maternal depression and SSRI antidepressants.
Rotem-Kohavi N; Williams LJ; Muller AM; Abdi H; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
Depress Anxiety; 2019 Aug; 36(8):753-765. PubMed ID: 31066992
[TBL] [Abstract][Full Text] [Related]
5. Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment.
Salisbury AL; Wisner KL; Pearlstein T; Battle CL; Stroud L; Lester BM
Depress Anxiety; 2011 Nov; 28(11):1008-19. PubMed ID: 21898709
[TBL] [Abstract][Full Text] [Related]
6. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
Casper RC; Gilles AA; Fleisher BE; Baran J; Enns G; Lazzeroni LC
Psychopharmacology (Berl); 2011 Sep; 217(2):211-9. PubMed ID: 21499702
[TBL] [Abstract][Full Text] [Related]
7. Mothers, Babies, Depression, and Medications: Understanding the Complex Interplay of Illness and Treatment on Neonatal Symptoms.
Chaudron LH
Am J Psychiatry; 2016 Feb; 173(2):101-2. PubMed ID: 26844789
[No Abstract] [Full Text] [Related]
8. Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure.
Oberlander TF; Grunau R; Mayes L; Riggs W; Rurak D; Papsdorf M; Misri S; Weinberg J
Early Hum Dev; 2008 Oct; 84(10):689-97. PubMed ID: 18639992
[TBL] [Abstract][Full Text] [Related]
9. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
10. Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromised.
Gustafsson HC; Goodman SH; Feng T; Choi J; Lee S; Newport DJ; Knight B; Pingeton B; Stowe ZN; Monk C
Dev Psychopathol; 2018 Aug; 30(3):773-785. PubMed ID: 30068426
[TBL] [Abstract][Full Text] [Related]
11. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
13. Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy.
Engelstad HJ; Roghair RD; Calarge CA; Colaizy TT; Stuart S; Haskell SE
Neonatology; 2014; 105(2):149-54. PubMed ID: 24356332
[TBL] [Abstract][Full Text] [Related]
14. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
[TBL] [Abstract][Full Text] [Related]
15. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior.
Zeskind PS; Stephens LE
Pediatrics; 2004 Feb; 113(2):368-75. PubMed ID: 14754951
[TBL] [Abstract][Full Text] [Related]
16. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.
Wisner KL; Sit DK; Hanusa BH; Moses-Kolko EL; Bogen DL; Hunker DF; Perel JM; Jones-Ivy S; Bodnar LM; Singer LT
Am J Psychiatry; 2009 May; 166(5):557-66. PubMed ID: 19289451
[TBL] [Abstract][Full Text] [Related]
17. Neonatal infant EEG bursts are altered by prenatal maternal depression and serotonin selective reuptake inhibitor use.
Grieve PG; Fifer WP; Cousy NP; Monk CE; Stark RI; Gingrich JA; Myers MM
Clin Neurophysiol; 2019 Nov; 130(11):2019-2025. PubMed ID: 31539768
[TBL] [Abstract][Full Text] [Related]
18. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
[TBL] [Abstract][Full Text] [Related]
19. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
[TBL] [Abstract][Full Text] [Related]
20. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.
Pawluski JL; Galea LA; Brain U; Papsdorf M; Oberlander TF
Pediatrics; 2009 Oct; 124(4):e662-70. PubMed ID: 19786426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
